Saloxicin By XYMOGEN Overview & Drug Interactions

Check For Interactions With Saloxicin

Supplement: Saloxicin by XYMOGEN

Saloxicin Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Saloxicin by XYMOGEN

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 60
UPC/BARCODE 871149000325

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Salicin
120 mg
Salicin --
Boswellia serrata extract
50 mg
Boswellia --
High ORAC Berry Blend
40 mg
Blend (Herb/Botanical) --
Strawberries
0 NP
Strawberry
Escobillo
0 NP
Acerola
Blueberries
0 NP
Blueberry
Cranberries
0 NP
cranberry
Grape extract
0 NP
Grape
Pomegranate extract
0 NP
Pomegranate

Other Ingredients:
HPMC
Tricalcium Phosphate
Microcrystalline Cellulose
Stearic Acid
Magnesium Stearate
Calcium Silicate
Silica


Label Statments:


Brand IP Statement(s)
- Not for resale on third-party websites, including, but not limited to, Amazon(R) and eBay(R).
- Saloxicin(TM) is formulated to support eicosanoid and cytokine balance and support for joint discomfort.
- 5-LOXIN(R), a patented Boswellia extract yielding concentrated 3-0-acetyl-11-keto-{Beta}-boswellic acid (AKBA), is found to inhibit the 5-lipoxygenase enzyme.
- Bioflavonoid-rich BerryVin(TM) provides additional support for cytokine balance and antioxidant activity.
- (C) 2015 XYMOGEN
- 5-Loxin(R) is a registered trademark of PL Thomas - Laila Nutra, LLC and is used under license. International Patents Pending. BerryVin(TM) is a trademark of Cyvex Nutrition, Inc.
Suggested/Recommended/Usage/Directions
- Directions: Take two capsules twice daily, or as directed by your healthcare practitioner.
Precautions
- Consult your healthcare practitioner prior to use.
- Individuals taking medication should discuss potential interactions with their healthcare practitioner.
- Do not use if tamper seal is damaged.
- Storage: Keep closed in a cool, dry place out of reach of children.
General Statements
- Salicin from white willow bark is a natural inhibitor of both the COX-2 and 5-lipoxygenase enzymes.
- ePV:
- Exclusive professional formulas
- Scan to learn more! {QRC}
- This package is completely recyclable
- Professional use only
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Storage
- Storage: Keep closed in a cool, dry place out of reach of children.
Formulation
- Does not contain: Wheat, gluten, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.
Seals/Symbols
- VEGETARIAN CAPS
- ePV
- THIRD-PARTY VERIFIED GMP COMPLIANT
General
- ZLB-SALOX-04 REV. 042315
Formula
- (Salix alba/Boswellia serrata)
FDA Statement of Identity
- Dietary Supplement

Brand Information

See all products by this brand

Manufacturer
Name XYMOGEN Exclusive Professional Formulas
Street Address 6900 Kingspointe Pkwy.
City Orlando
State FL
ZipCode 32819
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.